Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Review guidance for the identification and medical management of systemic sclerosis-associated ILD in this concise clinical review from the American Thoracic Society.
What you’ll learn:
- The pathogenesis of SSc-ILD
- The genetics and epigenetics associated with the disease
- The cellular pathogenesis of fibrotic lung injury in SSc
- Risk factors for the development and progression of SSc-ILD
- Blood serum and BAL fluid markers used in SSc-ILD diagnosis and prognostication
- Characteristics of IPF compared to SSc-ILD, and the importance of differentiation between the two diseases
Related Resources
Pulmonary Fibrosis – HCP Resource
Pulmonary Fibrosis and PDE4B – Video
The potential role of PDE4B.
View Resource
SSc-ILD - HCP Resource
Identification and Management of ILD in Systemic Sclerosis - Article
Read evidence-based consensus statements on guidance for the identification and medical management of SSc-ILD.
View Resource
SSc-ILD - HCP Resource
Systemic Sclerosis-Associated Interstitial Lung Disease - Slide Deck
Discover the epidemiology, pathogenesis, and diagnosis of SSc-ILD.
View Resource
